Respiratory vaccines specialist Vicebio Ltd. is to be acquired by Sanofi SA in a $1.6 billion deal, of which $1.15 billion will be paid up front. The acquisition rests on an ongoing phase I trial of ...

Biotechnology and biomedical engineering are distinct yet impactful fields shaping healthcare's future. Biotechnology delves ...